The IGF Axis in Prostate Cancer

E-ISSN： 1873-4286|13|7|719-727

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.7, 2007-03, pp. : 719-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the IGF1 axis in cancer proliferation

By Bruchim Ilan Attias Zohar Werner Haim

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. : 1179-1192

Informa Healthcare

Access to resources Recommend Favorite

Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer

By Buck Elizabeth Mulvihill Mark

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 605-621

Informa Healthcare

Access to resources Recommend Favorite

Atrasentan: targeting the endothelin axis in prostate cancer

By Jimeno Antonio Carducci Michael

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 12, 2004-12 ,pp. : 1631-1640

Informa Healthcare

Access to resources Recommend Favorite

Prostate Cancer Molecular Background: The IGF-1Ec Story

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 6-15

Bentham Science Publishers

Access to resources Recommend Favorite

Prostate Cancer Molecular Background: The IGF-1Ec Story

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 6-15

Bentham Science Publishers

Access to resources Recommend Favorite